3812 results for «211»

Filter By

3812 results

Rapid-Fire - TAVI and co-existent coronary artery disease

26 Nov 2024 – From PCR London Valves 2024

Explore a rapid-fire session featuring a selection of compelling clinical cases from PCR London Valves 2024. Discover how interventional cardiologists navigated complex scenarios, including overcoming late radiotherapy consequences, tackling challenging bicuspid aortic stenosis with left main disease, managing TAVI from elective to emergency, performing CTO intervention...

Rapid-Fire - TAVI and co-existent coronary artery disease

TAV-in-SAV for surgical bioprosthetic valve failure

26 Nov 2024 – From PCR London Valves 2024

Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...

TAV-in-SAV for surgical bioprosthetic valve failure

TAVI innovations: late-breaking trials from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.

You’ll dive into the CANNULATE TAVR EXTENDED...

TAVI innovations: late-breaking trials from PCR London Valves 2024

TAVI innovations: latest breakthroughs from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Opening ceremony

08 Apr 2017 – From PCR Tokyo Valves 2017

Closing Ceremony and Awards

09 Apr 2017 – From PCR Tokyo Valves 2017

PCR London Valves 2017 Opening Ceremony - Welcome address

25 Sep 2017 – From PCR London Valves 2017

PCR London Valves 2017

Welcome to Imaging Day

24 Sep 2017 – From PCR London Valves 2017

Welcome and introduction to PCR Innovators Day London

24 Sep 2017 – From PCR Innovators Day 2017

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

Didn’t find what you were looking for?